Depression :: Emsam – Selegiline as First Drug Patch for Depression

The Food and Drug Administration approved Emsam (selegiline), the first skin (transdermal) patch for use in treating major depression. The once a day patch works by delivering selegiline, a monoamine oxidase inhibitor or MAOI, through the skin and into the bloodstream. At its lowest strength, Emsam can be used without the dietary restrictions that are needed for all oral MAO inhibitors that are approved for treating major depression.

Cancer :: Initiative to Improve Cancer Therapy

The Food and Drug Administration (FDA), the National Cancer Institute (NCI), part of the National Institutes of Health, and the Centers for Medicare & Medicaid Services (CMS) today announced the Oncology Biomarker Qualification Initiative (OBQI) — an agreement to collaborate on improving the development of cancer therapies and the outcomes for cancer patients through biomarker development and evaluation.

Enuresis :: Homoeopathy in Enuresis – Bed Wetting

A very commonly seen problem in the clinic for which parents seek treatment and get concerned out of proportion. Children vary in the age at which they gain nocturnal continence of urine. About 10-15% of normal children at the age of 5 years still wet the bed at night. Boys slightly predominate over girls (as girls generally attain nocturnal bladder control early than boys), and there is increased incidence in some families. The factors leading to gaining in the bladder control are complex and involve maturation of the necessary neurological pathways as well as emotional factors.

Cosmetic Surgery :: Patient safety in medical spas, medispas

The American Academy of Cosmetic Surgery has released a white paper to its members and public concerning medical spas, a growing trend in cosmetic surgery. A medical spa is a facility offering a range of aesthetic procedures including both those typically offered in a spa, such as facials as well as non-invasive cosmetic surgery procedures such as fillers and laser treatments.

Health :: New Vaccine to Prevent Rotavirus Gastroenteritis in Infants

The Food and Drug Administration (FDA) announced the approval of RotaTeq, a live, oral, vaccine for use in preventing rotavirus gastroenteritis in infants. It is the only vaccine approved in the United States that can help protect against rotavirus, a viral infection that may cause diarrhea, vomiting, fever, and dehydration.

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | Health Newstrack